Ischemic stroke or transient ischemic attack
Conditions
Brief summary
(1) daily functioning, measured with the The Older Persons and Informal Caregivers Survey Short Form (TOPICS-SF), and (2) health related quality of life, measured using the PROMIS-10 with global mental health and global physical health summary scores, both at two years.
Detailed description
Secondary outcomes are daily functioning and hrQoL, both at one year. Other secondary outcomes are: physical functioning, functional outcome, cognition, emotional problems, falls, adverse drug events, cardiovascular risk status (based on clinical tests and lab results), general quality of life, societal costs, incidence of cardiovascular event recurrences and mortality - all at one and two years.
Interventions
DRUGAtorvastatine Accord 10 mg filmomhulde tabletten
Sponsors
Amsterdam UMC
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1) daily functioning, measured with the The Older Persons and Informal Caregivers Survey Short Form (TOPICS-SF), and (2) health related quality of life, measured using the PROMIS-10 with global mental health and global physical health summary scores, both at two years. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are daily functioning and hrQoL, both at one year. Other secondary outcomes are: physical functioning, functional outcome, cognition, emotional problems, falls, adverse drug events, cardiovascular risk status (based on clinical tests and lab results), general quality of life, societal costs, incidence of cardiovascular event recurrences and mortality - all at one and two years. | — |
Countries
Netherlands
Outcome results
None listed